Are phosphodiesterase type 5 inhibitors effective for the management of lower urinary symptoms suggestive of benign prostatic hyperplasia?

অনুরূপ উপাদানগুলি

• Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia, Erectile Dysfunction, and Phosphodiesterase-5 Inhibitors
  অনুযায়ী: Roehrborn, Claus G
  প্রকাশিত: (2004)
• Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
  অনুযায়ী: Pattanaik, Smita, অন্যান্য
  প্রকাশিত: (2018)
• Update on Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia
  অনুযায়ী: Elterman, Dean S, অন্যান্য
  প্রকাশিত: (2012)
• The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia
  অনুযায়ী: Umul, Mehmet, অন্যান্য
  প্রকাশিত: (2013)
• Phosphodiesterase type 5 inhibitors for treating erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia: A comprehensive review
  অনুযায়ী: Haddad, Albert, অন্যান্য
  প্রকাশিত: (2015)